ShareValue.ai

ShareValue scores for MBOT: Valuation 45, Quality 60, Growth 61, Health 47.

Microbot Medical Inc logo

MBOT
NASDAQ

Microbot Medical Inc

$1.77(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 16%
Valuation
45
Fair Value
Price vs Value
Quality
60
Moderate
Business Strength
Growth
61
Moderate
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
41
Neutral
Price Trend

Company Details

About

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026